Randomized phase III trial of adjuvant pazopanib versus placebo after nephrectomy in patients with locally advanced renal cell carcinoma (RCC) (PROTECT).
暂无分享，去创建一个
P. Russo | R. Motzer | T. Choueiri | C. Sternberg | B. Melichar | B. Rini | A. Stenzl | F. Donskov | L. Wood | Jae-Lyun Lee | M. Reaume | P. Aimone | N. Haas | M. Zemanova | D. Fahlenkamp | C. Doehn | Weichao Bao | S. Varlamov | E. Kopyltsov | M. Gross‐Goupil